Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

Find out why investment bank analysts are hyperbullish for these stocks.

2 Growth Stocks That Could Rocket 149% to 210% Higher in 2024, According to Wall Street

January 08, 2024

Iovance rebounded nicely after yesterday's drop, which came after the FDA put a clinical hold on its cancer-therapy trial.

Why Iovance Biotherapeutics Stock Popped Today

December 28, 2023

Bone Biologics Corp (NASDAQ: BBLG) shares are trading higher Thursday and has been halted multiple times despite a lack of company-specific news. Here's what you need to know.

What's Going On With Bone Biologics Corp Stock?

December 28, 2023

Via Benzinga

Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

December 28, 2023

Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program.

Via Benzinga

Investor Sentiment Edges Lower; Dow Jumps Over 100 Points

December 28, 2023

The CNN Money Fear and Greed index showed a decline in overall market sentiment, but the index remained in the "Extreme Greed" zone on Wednesday. U.S. stocks closed higher on Wednesday, with the Dow...

Via Benzinga

Topics Stocks

Crude Oil Falls Over 1%; First Wave BioPharma Shares Spike Higher

December 27, 2023

U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite moving lower on Wednesday. The Dow traded up 0.05% to 37,564.54 while the NASDAQ fell 0.04% to 15,069.30. The...

Via Benzinga

Topics Stocks

Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

December 27, 2023

Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per...

Via Benzinga

Why Iovance Biotherapeutics Stock Is Crashing Today

December 27, 2023

One of the small biotech's top pipeline programs ran into a major setback.

Another Wall Street analyst has jumped aboard the Iovance train.

Why Iovance Biotherapeutics Stock Is Jumping Today

November 20, 2023

Investors are excited by the prospects of a potential regulatory approval.

Why Iovance Biotherapeutics Stock Is Marching Higher Today

November 08, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 80 points on Wednesday. The Dow traded up 0.22% to 37,626.76 while the NASDAQ rose 0.06% to 15,084.02. The S&P...

10 Health Care Stocks Whale Activity In Today's Session

December 27, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session

December 27, 2023

Via Benzinga

Gold Gains 1%; Richmond Fed Manufacturing Index Falls In December

December 27, 2023

Via Benzinga

Topics Economy Stocks

Iovance Biotherapeutics, Nio, NetEase And Other Big Stocks Moving Lower On Wednesday

December 27, 2023

U.S. stocks traded mostly higher, with the Dow Jones index gaining around 80 points on Wednesday.

Via Benzinga

Topics Stocks

Analyst Expectations for Iovance Biotherapeutics's Future

November 08, 2023

Via Benzinga

Earnings Preview: Iovance Biotherapeutics

November 06, 2023

Via Benzinga

FDA Slaps Clinical Hold On Iovance Biotherapeutics' Lung Cancer Study After Patient Death

December 27, 2023

Wednesday, Iovance Biotherapeutics Inc (NASDAQ: IOVA) announced a clinical program update for LN-145 TIL therapy in non-

Via Benzinga

US Stocks Edge Higher; Coherus Reports FDA Approval Of UDENYCA ONBODY

December 27, 2023

U.S. stocks traded slightly higher this morning, with the Dow Jones index gaining more than 20 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.08% to 37,575.13 while...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

December 27, 2023

Via Benzinga

Iovance Biotherapeutics Announces Clinical Program Update for LN-145 in Non-Small Cell Lung Cancer

December 27, 2023

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

December 22, 2023

Both of these pharma stocks could be big winners. But one stock screens as a better buy from a risk standpoint.

Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics?

December 12, 2023

A Bull Market Is Coming: 1 Stock That Could Rocket 219% Higher in 2024, According to Wall Street

December 12, 2023

There's a huge gap between what the stock market and Wall Street analysts have to say about this often-overlooked growth stock.

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining over 100 points on Monday. The Dow traded up 0.34% to 35,064.42 while the NASDAQ rose 0.80% to 14,238.67. The S&P 500...

Crude Oil Gains Over 2%; PaxMedica Shares Plunge

November 20, 2023

Via Benzinga

Topics Stocks

Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session

November 20, 2023

Shares of ReNew Energy Global Plc (NASDAQ: RNW) gained during Monday’s session following strong quarterly sales. ReNew Energy Global posted quarterly sales of $345.00 million, topping market estimates...

Via Benzinga

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

November 17, 2023

Investors who are ready to dive into the OTC pool have more options than ever, both with the number of stocks to choose from and available investing platforms.

5 OTC Stocks With The Potential To Explode In 2024

November 08, 2023

Via Benzinga

Iovance Biotherapeutics Reports Third Quarter and Year-to-Date 2023 Financial Results and Corporate Updates

November 07, 2023

Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2023 Financial Results Conference Call and Webcast on Tuesday, November 7, 2023

October 31, 2023